TRILC PEER ANALYSIS

Turk Ilac Ve Serum Sanayi Anonim Sirketi — metric-by-metric comparison with peers and the industry median

TRILCTurk Ilac Ve Serum Sanayi Anonim Sirketi

🇹🇷 Turkey · IS · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

TRILCIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TRILC	BTAI	HIK	EGRX	ASRT	ANIK	Ind. Median
P/E	—	—	11.40	0.57●	—	—	21.35
P/B	0.61	-0.13●	1.77	0.03	2.00	1.62	1.77
EV/EBITDA	3.51	—	8.72	1.14●	—	—	12.18
P/S	0.23	19.75	1.37	0.03●	1.48	1.87	2.08

Financial Health
Metric	TRILC	BTAI	HIK	EGRX	ASRT	ANIK	Ind. Median
Current Ratio	0.99	0.62	1.82	2.16	1.82	4.46●	2.22
Debt/Equity	207.6%	-95.0%●	61.8%	28.4%	53.3%	19.2%	46.3%
NetDebt/EBITDA	2.71	-1.44●	1.87	0.99	5.39	3.30	1.24

Profitability
Metric	TRILC	BTAI	HIK	EGRX	ASRT	ANIK	Ind. Median
Net Margin	-2.2%	-11,078.5%	12.0%●	6.0%	-34.9%	-9.5%	4.0%
ROE	-6.0%	—	16.4%●	6.4%	-38.8%	-7.8%	6.4%
ROA	-1.8%	-207.6%	7.5%●	4.0%	-14.3%	-6.0%	3.4%
EBITDA Margin	28.5%●	-8,509.3%	20.0%	22.1%	-5.7%	-4.0%	18.2%

Growth + Dividend
Metric	TRILC	BTAI	HIK	EGRX	ASRT	ANIK	Ind. Median
Rev. Growth	32.0%●	-63.3%	7.4%	-5.4%	-14.2%	23.2%	7.5%
NI Growth	—	—	12.2%●	-31.7%	—	—	5.0%
Div. Yield	0.0%	—	5.4%●	2.8%	—	—	2.0%
Payout	0.0%	—	45.2%	1.6%	—	—	0.8%

Valuation
Metric	TRILC	SEYKM	RTALB	ANGEN	LKMNH	MEDTR	Ind. Median
P/E	—	264.22	4.89●	—	22.46	596.83	21.35
P/B	0.61●	1.64	0.61	1.32	1.16	1.08	1.77
EV/EBITDA	3.51●	416.64	74.61	34.77	4.65	10.93	12.18
P/S	0.23●	3.50	6.67	2.95	0.71	1.18	2.08

Financial Health
Metric	TRILC	SEYKM	RTALB	ANGEN	LKMNH	MEDTR	Ind. Median
Current Ratio	0.99	6.82●	1.21	2.31	0.83	3.58	2.22
Debt/Equity	207.6%	0.0%●	1.2%	28.1%	99.0%	1.0%	46.3%
NetDebt/EBITDA	2.71	-168.37●	0.90	4.71	1.96	-1.64	1.24

Profitability
Metric	TRILC	SEYKM	RTALB	ANGEN	LKMNH	MEDTR	Ind. Median
Net Margin	-2.2%	1.3%	136.3%●	-45.0%	3.2%	0.2%	4.0%
ROE	-6.0%	0.7%	15.1%●	-21.0%	5.6%	0.2%	6.4%
ROA	-1.8%	0.6%	13.1%●	-15.7%	2.7%	0.2%	3.4%
EBITDA Margin	28.5%●	0.6%	9.0%	9.8%	26.4%	9.4%	18.2%

Growth + Dividend
Metric	TRILC	SEYKM	RTALB	ANGEN	LKMNH	MEDTR	Ind. Median
Rev. Growth	32.0%●	-24.8%	24.0%	11.7%	19.8%	6.5%	7.5%
NI Growth	—	—	134.0%●	—	-44.2%	-62.9%	5.0%
Div. Yield	0.0%	0.0%	0.0%	0.0%	3.6%●	1.1%	2.0%
Payout	0.0%	0.0%	0.0%	0.0%	81.3%	656.3%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TRILC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.